| Identification | Back Directory | [Name]
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid | [CAS]
1012341-52-4 | [Synonyms]
LCZ706
LCZ696-20
impurity 21
LCZ696696-A-A
LCZ696 impuritiesE
LCZ-696 Impurity 17
LCZ 696 Impurity E
LCZ696 impurities125
Sacubitril Impurity 2
Sacubitril Impurity E
LCZ-696 Impurity 17(S,S)
LCZ696(valsartan + sacubitril) impurity 21
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
(2S,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
(αS,γS)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1-biphenyl]-4-pentanoic Acid
1,1'-Biphenyl]-4-pentanoic acid, γ-[[(1,1-dimethylethoxy)carbonyl]amino]-α-methyl-, (αS,γS)-
(αS,?γS)?-γ-?[[(1,?1-?Dimethylethoxy)?carbonyl]?amino]?-?α-?methyl-[1,?1'-?biphenyl]?-?4-?pentanoic Acid | [Molecular Formula]
C23H29NO4 | [MDL Number]
MFCD28386951 | [MOL File]
1012341-52-4.mol | [Molecular Weight]
383.48 |
| Chemical Properties | Back Directory | [Boiling point ]
582.6±50.0 °C(Predicted) | [density ]
1.115±0.06 g/cm3(Predicted) | [pka]
4?+-.0.23(Predicted) | [InChI]
InChI=1/C23H29NO4/c1-16(21(25)26)14-20(24-22(27)28-23(2,3)4)15-17-10-12-19(13-11-17)18-8-6-5-7-9-18/h5-13,16,20H,14-15H2,1-4H3,(H,24,27)(H,25,26)/t16-,20-/s3 | [InChIKey]
YNELJETWNMPEEH-HLGVANASNA-N | [SMILES]
C(O)(=O)[C@@H](C)C[C@H](NC(OC(C)(C)C)=O)CC1=CC=C(C2=CC=CC=C2)C=C1 |&1:3,6,r| |
| Hazard Information | Back Directory | [Uses]
(αS,?γS)?-γ-?[[(1,?1-?Dimethylethoxy)?carbonyl]?amino]?-?α-?methyl-[1,?1''-?biphenyl]?-?4-?pentanoic Acid is a useful synthetic intermediate. |
|
| Company Name: |
Roark Standards
|
| Telephone: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
|